Honig PK. The "Coming of Age" of Real-World Evidence in Drug Development and Regulation.
Clin Pharmacol Ther 2021;
111:11-14. [PMID:
34914104 DOI:
10.1002/cpt.2465]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2021] [Accepted: 10/26/2021] [Indexed: 12/25/2022]
Abstract
Real world evidence (RWE) has the potential to inform drug discovery, development, and regulatory decision making. The emergence and availability of large population-based datasets around the globe have stoked enthusiasm in the research community. However, much work remains to refine research methodologies, evolve the science, and define the place of RWE as a complementary source of evidence to randomized controlled trials.
Collapse